(±)-Rolipram – (61413-54-5)

Diamfenetide, 36141-82-9, Acemidophene, Diamphenethide, Diamfenetida, Coryphamin, Compound 68-198, Diamfenetide [INN], Diamfenetidum, Diamfenetidum [INN-Latin], Diamfenetida [INN-Spanish], Diamfenetide [INN:BAN], U4TFJ7GB6T, EINECS 252-886-5, beta, beta'-Oxybis(p-acetophenetidide), NSC 291838, NSC-291838, BRN 2179741, 4, 4'-Oxybis(ethylenoxy)bis(acetanilid), Acetamide, N, N'-(oxybis(2, 1-ethanediyloxy-4, 1-phenylene))bis-, DTXSID5046229, WR 219124, DIAMFENETIDE [MI], DIAMFENETIDE [MART.], COMPOUND-68-198, DTXCID3026229, N, N'-(Oxybis(2, 1-ethanediyloxy-4, 1-phenylene))bisacetamide, N-[4-[2-[2-(4-acetamidophenoxy)ethoxy]ethoxy]phenyl]acetamide, 4-13-00-01099 (Beilstein Handbook Reference), N, N'-(((oxybis(ethane-2, 1-diyl))bis(oxy))bis(4, 1-phenylene))diacetamide, NCGC00160558-01, Diamfenetidum (INN-Latin), Diamfenetida (INN-Spanish), DIAMFENETIDE (MART.), .BETA., .BETA.'-OXYBIS(P-ACETOPHENETIDIDE), Acemidophen, Acetamide, N, N'-[oxybis(2, 1-ethanediyloxy-4, 1-phenylene)]bis-, .beta., .beta.'-Oxybis[p-acetophenetidide], CAS-36141-82-9, UNII-U4TFJ7GB6T, N, N'-[oxybis(2, 1-ethanediyloxy-4, 1-phenylene)]bisacetamide, MFCD00360595, Di-(2-(4-acetamidophenoxy)ethyl) Ether, MLS004774073, SCHEMBL168664, CHEMBL2104259, JNEZCZPNQCQCFK-UHFFFAOYSA-N, Tox21_111898, NSC291838, STK368723, AKOS005444311, Tox21_111898_1, NCGC00160558-02, SMR002529957, Diamfenetide 100 microg/mL in Acetonitrile, HY-119893, CS-0078289, NS00029982, G66217, SR-01000883941, SR-01000883941-1, Q27290692, Acetamide, N'-[oxybis(2, 1-ethanediyloxy-4, 1-phenylene)]bis-, N, N'-[oxybis(ethane-2, 1-diyloxybenzene-4, 1-diyl)]diacetamide, N-(4-(2-(2-(4-(ACETYLAMINO)PHENOXY)ETHOXY)ETHOXY)PHENYL)ACETAMIDE, 252-886-5